Deep knowledge on 
 small-molecule drugs and 
 the 100,000 global patents 
 covering them 

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: albuterol sulfate; ipratropium bromide

« Back to Dashboard
Albuterol sulfate; ipratropium bromide is the generic ingredient in four branded drugs marketed by Apotex Inc, Teva Pharms, Boehringer Ingelheim, Nephron, Mylan Speclt, Cipla Ltd, Watson Labs, Sandoz Inc, and Ritedose Corp, and is included in ten NDAs. There are nineteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has four hundred and ninety-one patent family members in forty-six countries.

There are thirty-five drug master file entries for albuterol sulfate; ipratropium bromide. Five suppliers are listed for this compound.

Summary for Generic Name: albuterol sulfate; ipratropium bromide

Tradenames:4
Patents:19
Applicants:9
NDAs:10
Drug Master File Entries: see list35
Suppliers / Packaging: see list12

Pharmacology for Ingredient: albuterol sulfate; ipratropium bromide

Clinical Trials for: albuterol sulfate; ipratropium bromide

Budesonide Inhalation Suspension for Acute Asthma in Children
Status: Completed Condition: Asthma; Acute Asthma; Reactive Airway Exacerbation

Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD
Status: Completed Condition: Pulmonary Disease, Chronic Obstructive

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim
COMBIVENT RESPIMAT
albuterol sulfate; ipratropium bromide
SPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYes6,149,054<disabled>Y <disabled>
Nephron
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
albuterol sulfate; ipratropium bromide
SOLUTION;INHALATION076749-001Dec 31, 2007RXNo<disabled><disabled>
Boehringer Ingelheim
COMBIVENT RESPIMAT
albuterol sulfate; ipratropium bromide
SPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYes7,988,001<disabled>Y <disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: albuterol sulfate; ipratropium bromide

These historical archives are available as an add-on to one-year subscriptions

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim
COMBIVENT RESPIMAT
albuterol sulfate; ipratropium bromide
SPRAY, METERED;INHALATION021747-001Oct 7, 20115,405,084<disabled>
Boehringer Ingelheim
COMBIVENT RESPIMAT
albuterol sulfate; ipratropium bromide
SPRAY, METERED;INHALATION021747-001Oct 7, 20116,503,362<disabled>
Boehringer Ingelheim
COMBIVENT RESPIMAT
albuterol sulfate; ipratropium bromide
SPRAY, METERED;INHALATION021747-001Oct 7, 20115,911,851<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: albuterol sulfate; ipratropium bromide

Country Document Number Publication Date
Israel140221Oct 31, 2003
Denmark1017469Mar 17, 2003
Canada2552535Jul 21, 2005
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc